Clene Inc CLNN

US Biotechnology

$4.30 ▲ +2.14% (+$0.09)

🎈 Low Float

Open $4.15

Prev Close $4.21

Day Range $4.12 – $4.49

52W Range $3.25 – $13.50

Market Cap $61.12M

Beta 1.05

EPS (TTM) $-3.49

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2018-08-27
Shares Out.	12,780,000
Website	clene.com/ ↗
Phone	18003464646
Employees	79
Revenue	$90,000
Gross Profit	$54,000
Net Income	-$13.4M
Free Cash Flow	-$15.9M
Total Assets	$23.0M
Total Liabilities	$47.8M
Equity	-$24.8M

About Clene Inc

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Clene Inc is a publicly traded company under the ticker symbol CLNN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.